Ponte Academic Journal Nov 2022, Volume 78, Issue 11 |
ARE SOME INFLAMMATORY MARKERS BETTER THAN OTHERS AT DETERMINING GASTRIC CANCER PROGNOSIS? Author(s): Nilufer Bulut ,Berrak Sahtiyanci J. Ponte - Nov 2022 - Volume 78 - Issue 11 doi: 10.21506/j.ponte.2022.11.15 Abstract: Purpose: In patients with stomach cancer, the inflammatory response of the host, and tumor markers, play essential roles in determining the prognosis. This study aimed to predict prognosis in previously untreated gastric cancer patients using inflammatory markers. Materials and Methods: This retrospective study evaluated 100 patients with stomach cancer, treated between 2015 and 2018. Pre-and postoperative blood samples were analyzed for the neutrophil/lymphocyte ratio (NLR), the platelet/lymphocyte ratio (PLR), the systemic inflammatory index (SII), and other immune markers. Results: The survival rate was significantly higher in patients with an SII level < 1190.4 compared to patients with an SII level > 1190.4 (p < 0.05). The disease-free survival was 47.7 months in the group with a low SII (84.4%) and 37 months in the group with a high SII (80%). In the ROC analysis, the AUC for NLR, PLR, and SII was 0.611, 0.65, and 0.64, respectively (p-values: 0.058, 0.010, and 0.011). The preoperative values were not significant; however, the postoperative values were significant for prognosis. Conclusion: During the pre-and postoperative periods, analysis of the inflammatory markers (NLR, PLR, and SII) guides the treatment and follow-up as much as the histopathological features of the tumor. High NLR and SII levels shortened overall survival during the 4-year follow-up.
|
Download full text: Check if you have access through your login credentials or your institution |
|
Guide for Authors
This guideline has been prepared for the authors to new submissions and after their manuscripts have been accepted |
Authors Login
We welcome refrees who would be willing to act as reviewers |
Paper Tracking
You can track your submitted article from this tab |
Editorial Board
The international editorial board is headed by Dr. Maria E. Boschi |
General Policies
Papers that are published or held by the Journal may not be published elsewhere |
Peer Review Process
Papers will be sent to three peer reviewers for evaluation |